Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndromeCentral MessagePerspective by Rachel E. Wittenberg, BS, Kimberlee Gauvreau, ScD, Jonah Leighton, CST, Melinda Moleon-Shea, BS, Kenneth M. Borow, MD, Gerald R. Marx, MD, Sitaram M. Emani, MD

Get full text